Raptor Pharmaceutical Hires Patrick Reichenberger to Lead Commercial Development of DR Cysteamine for Nephropathic …

Raptor Pharmaceutical Corp. 10.01.2011 12:30 ————————————————————————— Contracts in Place for Cambrex Corporation and Patheon, Inc. to Manufacture Active Pharmaceutical Ingredient and Commercial Product, Respectively NOVATO, Calif., 2011-01-10 12:30 CET (GLOBE NEWSWIRE) –Raptor Pharmaceutical Corp. (‘Raptor’ or the ‘Company’) (Nasdaq:RPTP …

View full post on web development – Yahoo! News Search Results

VN:F [1.9.22_1171]
Rating: 0.0/10 (0 votes cast)
VN:F [1.9.22_1171]
Rating: 0 (from 0 votes)